Abstract: The invention concerns a device for vaporizing injections of samples into a gas chromatography analysis device, comprising a vaporization chamber elongated lengthways and heated, as well as a syringe equipped with a needle, the device being of the type in which the introduction of the sample is carried out without prior vaporization of the sample within the needle, and also foresees at least one stop and vaporization means for the liquid inside the vaporization chamber. To improve the conditions of vaporization and the transfer of the sample, the distance between the free end of the needle and the stated stop and vaporization means for the liquid is greater than 55 mm (FIG. 1).
Type:
Grant
Filed:
July 3, 2001
Date of Patent:
August 24, 2004
Assignee:
Thermo Finnigan Italia S.p.A.
Inventors:
Konrad Grob, Fausto Munari, Paolo Magni
Abstract: Provided herein are racemic or enantiomerically enriched benzoyl piperidine compounds and pharmaceutically useful salts thereof, pharmaceutical compositions comprising an effective amount of racemic or enantiomerically enriched benzoyl piperidine compounds to treat central nervous system diseases and methods of treating central nervous system diseases in a mammal, in particular psychoses and cognition disorders.
Type:
Grant
Filed:
August 26, 2002
Date of Patent:
August 3, 2004
Assignee:
SK Corporation
Inventors:
Yong-Moon Choi, Yong-Kil Kim, Jin-Uk Yoo, Eun-Ah Paek, Chun-Eung Park, Sung-Yong Seo, Coo-Min Chung, Joon Heo
Abstract: A low-power, fully self-contained fingerprint capture, enrollment and verification method and device (100). The device includes a logic unit (110), a memory (120), a fingerprint sensor (130) and an interface (150) to an external unit (140). Included in the memory is a program (126) that includes a sensor data capture module (200), an image processing module (202), a minutia extraction module (204), a template creation module (206), a template compare module (208), and a database (210). The processes for capturing, enrolling and verifying a fingerprint are designed to be minimally computationally intensive. This allows implementation of these processes in a portable, battery-powered unit using hardware with limited memory and computing capability, or implementation in a PC with substantial performance advantages relative to known fingerprint capture, enrollment and verification processes and devices.
Abstract: Process for producing a tool insert for injection molding a part which is produced from a synthetic material, a metal or a ceramic material and which comprises an arrangement of microstructures which are formed on an outer surface of the part and have a predetermined depth.
Abstract: The present invention provides an improved method of alerting a remote device in an idle state over a channel. A value R1, which is the location of an initial PI bit within an initial half of at least one time slot on the channel, is computed based on a hashing algorithm defined in IS-2000 that uses information about the remote device. The initial indicator bit is assigned a binary value by the base station. Then, a value R2, which is the location of a further bit on a further half of the at least one time slot on the channel, is computed based on an improved hashing algorithm. Then, the further indicator bit is assigned a binary value by the base station. Then, the remote device in the idle state is alerted over the channel based on the assigned bit location R1 and further bit location R2.
Abstract: A work station that includes a mobile cabinet and a storage compartment. The storage compartment rests on top of the cabinet and is secured to the cabinet. The storage compartment projects beyond a periphery of the topside of the cabinet. The storage compartment includes a bottom, sidewalls and a lid. The bottom may be secured to the topside of the cabinet. The sidewalls extend upwardly from the bottom on three sides. The lid has a front from which extends a front side. The lid may be hinged to two opposing ones of the sidewalls and be swung between an open position and a closed position. Between the lid and the cabinet is a surface with an opening.
Abstract: A golf ball stacking and dispensing apparatus comprising a hopper having two pyramidal shells each of different dimensions. Each of the shells is truncated and has a respective open substantially rectangular rim defining a respective open base of a different dimension than that of the other. The shells are joined together where each is truncated so as to converge together and define a funnel opening between the shells. Each of the shells is configured to form a self-supporting stack of golf balls atop each other as a stacking tray closes the open base of one of the shells and the golf balls are poured through the other of the shells. A method of forming different size pyramidal stacks of golf balls by pouring golf balls through one pyramidal shell of a hopper to fill the other pyramidal shell thereof.
Abstract: Telephone network service logic relating to calls over the telephone network to a customer terminal, uses both terminal functions and network functions. The terminal has a service logic script for execution at the terminal to control the terminal functions. To control the execution of this script remotely from the network, a script-control message is determined and sent over the telephone network to the terminal. This may use the GR30 message format, with an additional call qualifier specific to the terminal service logic script, and the type of control being requested, e.g., start execution or terminate the script. This enables the reliability of the interaction between the service logic at the network side, and the service logic script at the terminal to be improved. This enables announcement type services to be provided in which a loudspeaker on the terminal can be remotely controlled to make verbal announcements without requiring customer action to lift a receiver.
Type:
Grant
Filed:
September 23, 1999
Date of Patent:
June 1, 2004
Assignee:
Nortel Networks Limited
Inventors:
Bernard Chin, Brian Buckler, Sandro Cianci
Abstract: A self-aligning type of detachable rigid connection device having at least one main body endowed with a seat and at least one supported element endowed with a shank to be received into the seat of the main body. An actuator is provided for elastically deforming the shank and bringing at least two external surfaces of the same into close contact with the inside surface of the seat.
Abstract: The invention provides new macrolides antibiotics of formula I with improved biological properties and improved stability of the formula
wherein
R1 is hydrogen, cyano, —S(L)mR2, —S(O)(L)mR2, or —S(O)2(L)mR2;
L represents —(CH2)n— or —(CH2)nZ(CH2)n′—;
m is 0 or 1;
n is 1, 2, 3, or 4;
n′ is 0, 1, 2, 3, or 4;
Z is O, S or NH;
R2 is hydrogen, alkyl, heterocyclyl or aryl; which heterocyclyl and the aryl groups may be further substituted;
* indicates a chiral center which is in the (R) or (S) form,
as well as a pharmaceutically acceptable acid addition salts or in vivo cleavable esters thereof.
Type:
Grant
Filed:
February 21, 2003
Date of Patent:
May 25, 2004
Assignee:
BAsilea Parmaceutica AG
Inventors:
Peter Angehrn, Daniel Hunziker, Pierre-Charles Wyss
Abstract: The present invention relates to compositions comprised of a peptide ligand or derivatives thereof that are capable of specific binding to the high affinity receptor-1 of vascular endothelial growth factor (VEGF) and structure similar receptors. The invention further provides a peptide ligand or derivatives thereof that are capable of inhibiting angiogenesis induced by VEGF. The present invention also provides a method for treatment or diagnosis of disease associated with angiogenesis in a patient in need of therapy comprising administering to the patient an effective amount of the pharmaceutical composition of the present invention and a pharmaceutical acceptable carrier.
Type:
Grant
Filed:
February 2, 2001
Date of Patent:
May 11, 2004
Assignee:
Supratek Pharma, Inc.
Inventors:
Lioudmila Tchistiakova, Shengmin Li, Grzegorz Pietrzynski, Valery Alakhov
Abstract: Monoclonal antibodies against dihydropyrimidine dehydrogenase are disclosed. Immunologic assays using the monoclonal antibodies are also disclosed.
Abstract: The apparatus of timepieces which provide an unobstructed central area of a permanent opaque face for enhanced display of artwork, logos, holograms, text, designs and/or pictures which enables the wearer to discern the time.
Abstract: This invention relates to a nutritional intervention composition in a dry power form for enhancing satiety prior to a meal and extending satiety after a meal in a calorically efficient fashion. The dry nutritional composition includes protein, caseinmacropeptides (CMP) or glycomacropeptides (GMP) or any hydrolysis product of GMP, long chain fatty acids, soluble and/or insoluble fibers. The dry nutritional composition includes protein in the range of 0.21% to 88.30%, glycomacropeptide in the range of 0.05% to 87.72%, oleic acid in the range of 2.27% to 97.25%, soluble fibers in the range of 0.19% to 79.05%, and insoluble fibers in the range of 0.19% to 79.05%. The composition may also include plant saponins, calcium and cholestyramine.
Abstract: The present invention relates to an improvement in the recovery of boron values from a mixture of alkali metal borate and alkali metal hydroxide representing discharged fuel from a hydrogen generator apparatus. The mixture is reacted with carbon dioxide and a lower alcohol to form trialkyl borate, alkali bicarbonate and water. A porous water-absorbing material is added to the reaction mixture to absorb water as it forms thereby improving the yield of trialkyl borate. The trialkyl borate is converted to alkali borohydride that is used in the fuel.
Abstract: This invention relates to indole derivatives of the general formula (I) wherein R1 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, alkylsulfonyl, cycloalkylsulfonyl, cycloalkylalkylsulfonyl, dialkylsulfamoyl, N-cycloalkyl-N-alkylsulfamoyl, heterocyclylalkyl or phenylalkyl; R2 is hydrogen, halogen, alkyl, alkanoyl, phenyl, phenylalkyl or heterocyclylalkyl; R3 is hydrogen, alkyl; and R4 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, alkylsulfonyl, cycloalkylsulfonyl, cycloalkylalkylsulfonyl, dialkylsulfamoyl, N-cycloalkyl-N-alkylsulfamoyl, heterocyclylalkyl, or phenylalkyl; and pharmaceutically acceptable acid addition salts of these compounds, there use as therapeutically active substances; medicaments based on these substances, optionally in combination with sulphonamides, and their production; the use of these substances as medicaments and for the production of antibacterially-active medicaments; as well as the manufacture of the compounds of formula (I) and their pharmaceutically acceptab